- Moving forward at cruising speed
- Want to stay on the market with your biocidal product after 1 September 2015?
- Implementing biocides in a Member State - a Dutch perspective
- An industry perspective: Challenges for generating safe use information for mixtures
- What happens after a decision has been made on a dossier?
- Helping SMEs
- Improving quality of nanomaterial registrations
- Checking compliance - lessons learnt and recommendations
- Working for scientifically sound opinions
- New Head of Unit for ICT Infrastructure and IT Security
- A shock that led to a documentary: "Products on the shelves are not tested for safety"
- Guest column: Nanotechnology Industries Association's view on nanomaterials under REACH
- "Protecting health and the environment is a global goal"
- Advocating for transparency of chemical data
Send your feedback to:echanewsletter (at) echa.europa.eu
Autumn has arrived in Helsinki with leaves falling from the trees and nightly temperatures falling below zero. The lovely, romantic Finnish tradition of wood fires and candles is now in full swing. (By the way, a number of you have commented on my regular references to the weather, to which my only response is "I'm British", and you know how important the weather is for us!).
If so, you need to get on the list of active substance suppliers (Article 95 of the Biocidal Products Regulation) or ensure that your active substance supplier gets on the list. Following the steps below will guide you through the process and tells you where to find additional information and help.
New ways of working internally, new partners to cooperate with and new IT-tools to be used - these are some of the challenges that the Dutch competent authority for biocides, Ctgb, has faced. Since the Ctgb started working with biocides applications long before the Biocidal Products Regulation came along, the structures were already in place to take on the new responsibilities. However, many aspects of the work have changed during the last year. ECHA Newsletter spoke with three colleagues from the Ctgb to find out how the new regulation has affected their daily work and their organisation.
Communicating about safety
Communicating exposure scenarios and other information for mixtures further downstream is a complex task for industry. One approach formulators take is to develop safe use information based on the substances that present the greatest hazard and risk. "This is a good starting point," our guest contributors say. However, formulators are faced with various challenges. Our contributors tell us more.
News from ECHA
ECHA has published a new fact sheet describing what happens after dossier evaluation decisions. It explains the steps after the registrant has received ECHA's decision requesting further information by a given deadline.
Undoubtedly, the EU chemicals legislation brings benefits for society. But there are gains for industry, too. Companies have developed a clearer insight into their product portfolios and addressed more systematically the hazards of the industrial chemicals that they place on the market. By identifying their uses, they have helped establish a better picture of the risks that merit dedicated risk management measures. Such stewardship contributes to the protection of human health and of the environment. It also helps identify potential for innovation.
The first of ECHA's strategic aims for 2014-2018 is to improve the quality of registration dossiers - including information on nanomaterials.
The final report on the outcomes of the second EU wide harmonised enforcement project was published in September.
ECHA's two Committees, the Committee for Risk Assessment (RAC) and Committee for Socio-economic Analysis (SEAC), prepare ECHA's opinions on restrictions, applications for authorisation and harmonised classification and labelling. Their task is to help ensure sound scientific opinion making that can be supported by the European Commission and advance the goals of REACH and CLP. But what exactly is it like to be a committee member? ECHA Newsletter finds out.
As of 1 September 2013, Mr Orion Andrews has been appointed Head of the ICT Infrastructure and IT Security Unit. His main task will be to manage the implementation of the Agency's IT strategy, ensuring that ECHA's ICT infrastructure, technical services, and IT security management function well.
People and perspectives
The Human Experiment is a new American documentary focusing on chemicals in everyday household products and their potential effect on humans. The film includes interviews with ECHA's Executive Director Geert Dancet and Director Jack de Bruijn, which showcase the advances in chemicals legislation in Europe. It will premiere at the International Documentary Film Festival in Amsterdam in November. ECHA Newsletter spoke with Dana Nachman, one of the directors, to find out what inspired the film and what she hopes people will get out of it.
Since the beginning of REACH, which coincided more or less with the increasing political interest in nanomaterials, discussions have been ongoing as to how nanomaterials ought to be managed under REACH.
REACH plays an important role in protecting human health and the environment from hazardous chemicals. The non-governmental organisations (NGOs) ensure that civil society is represented in the process. ECHA Newsletter met with Tatiana Santos from the European Environmental Bureau (EEB) to discuss the cooperation of NGOs and ECHA as well as the challenges and benefits of REACH.
As a representative of the NGO ClientEarth, one of ECHA's Accredited Stakeholder Organisations, Brussels-based Italian lawyer Vito Buonsante regularly travels to Helsinki, where he actively participates in the implementation of REACH. Although sometimes critical of ECHA's role, Buonsante hopes REACH will be the vehicle for the EU to be a leader in green chemistry.
Biocidal Products Committee:
26 February-1 March
Committee for Risk Assessment:
6-8 March and
Committee for Socio-Economic
Management Board meeting:
23-27 March (tentative)
Member State Committee:
20-24 April (tentative)